Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-08-21 13:57 CEST (UTC+2h)
 
mmw
Junior

India,
2017-07-14 14:50

Posting: # 17548
Views: 556
 

 EMA Product Specific GL [Regulatives / Guidelines]

Dear all,

EMA adopted a new batch of product specific guidances. Published on 10/07/2017:

Crizotinib
Elvitegravir / cobicistat / emtricitabine / te­no­fovir disoproxil
Elvitegravir
Emtricitabine, rilpivirine, tenofovir, disopro­xil
Vortioxetine

Thanks

MMW
Helmut
Hero
Homepage
Vienna, Austria,
2017-07-28 12:40

@ mmw
Posting: # 17620
Views: 304
 

 EMA Product Specific GL


[image]All the best,
Helmut Schütz 
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Helmut
Hero
Homepage
Vienna, Austria,
2017-08-03 17:47

@ Helmut
Posting: # 17660
Views: 210
 

 tlag‽

Dear all,

In the product-specific guidance for Dimethyl fumarate gastro-resistant capsules 120 mg and 240 mg we find:

Main pharmacokinetic variables:
Single dose: AUC0-t, AUCinf, Cmax (tlag and tmax)
90% confidence interval: 80.00–125.00% for AUC0-t, AUCinf, Cmax. Comparable median and range for tlag and tmax.


I beg your pardon, tlag
For delayed release products any change in tlag directly translates into a shifted tmax (see this presentation, slides 53–58). Whilst the latter PK metric is generally already covered by rich sampling (in order to “catch” Cmax) this is not the case for tlag. I don’t get it.

[image]All the best,
Helmut Schütz 
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum | Admin contact
17,225 Posts in 3,685 Threads, 1,056 registered users;
40 users online (0 registered, 40 guests).

The important thing in science is not so much to obtain new facts
as to discover new ways of thinking about them.    William Henry Bragg

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed